Table 2.
Clinical data of COVID-19 self-isolation patients.
| Outcome | p value | OR | CI | ||
|---|---|---|---|---|---|
| Better | Worse | ||||
| Gender | |||||
| Male | 102 (51.8%) | 9 (4.6%) | 0.994∗ | 1.004 | 0.358–2.814 |
| Female | 79 (40.1%) | 7 (3.6%) | |||
|
| |||||
| Age | |||||
| <45 years old | 96 (48.7%) | 5 (2.5%) | 0.095∗ | 2.485 | 0.830–7.440 |
| >45 years old | 85 (43.1%) | 11 (5.6%) | |||
|
| |||||
| Clinical degree | |||||
| Asymptomatic-mild | 124 (62.9%) | 4 (2.0%) | 0.000∗ | 6.526 | 2.017–21.117 |
| Moderate-severe | 57 (28.9%) | 12 (6.1%) | |||
|
| |||||
| Vaccine | |||||
| Yes | 132 (67.0%) | 13 (6.6%) | 0.469∗ | 0.622 | 0.170–2.275 |
| No | 49 (24.9%) | 3 (1.5%) | |||
|
| |||||
| Antiviral | |||||
| Yes | 111 (56.3%) | 13 (6.6%) | 0.114∗ | 0.366 | 0.101–1.330 |
| No | 70 (35.5%) | 3 (1.5%) | |||
|
| |||||
| Antibiotic | |||||
| Yes | 123 (62.4%) | 15 (7.6%) | 0.031∗ | 0.141 | 0.018–1.096 |
| No | 58 (29.4%) | 1 (0.5%) | |||
∗Chi-square.